JP2021512109A5 - - Google Patents

Info

Publication number
JP2021512109A5
JP2021512109A5 JP2020541807A JP2020541807A JP2021512109A5 JP 2021512109 A5 JP2021512109 A5 JP 2021512109A5 JP 2020541807 A JP2020541807 A JP 2020541807A JP 2020541807 A JP2020541807 A JP 2020541807A JP 2021512109 A5 JP2021512109 A5 JP 2021512109A5
Authority
JP
Japan
Prior art keywords
alkyl
independently selected
group
optionally substituted
substituents independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020541807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512109A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/016098 external-priority patent/WO2019152678A1/en
Publication of JP2021512109A publication Critical patent/JP2021512109A/ja
Publication of JP2021512109A5 publication Critical patent/JP2021512109A5/ja
Priority to JP2023192455A priority Critical patent/JP2024019396A/ja
Pending legal-status Critical Current

Links

JP2020541807A 2018-01-31 2019-01-31 スピロラクタム系nmda受容体修飾因子およびその使用 Pending JP2021512109A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023192455A JP2024019396A (ja) 2018-01-31 2023-11-10 スピロラクタム系nmda受容体修飾因子およびその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862624218P 2018-01-31 2018-01-31
US62/624,218 2018-01-31
US201862718107P 2018-08-13 2018-08-13
US62/718,107 2018-08-13
PCT/US2019/016098 WO2019152678A1 (en) 2018-01-31 2019-01-31 Spiro-lactam nmda receptor modulators and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023192455A Division JP2024019396A (ja) 2018-01-31 2023-11-10 スピロラクタム系nmda受容体修飾因子およびその使用

Publications (2)

Publication Number Publication Date
JP2021512109A JP2021512109A (ja) 2021-05-13
JP2021512109A5 true JP2021512109A5 (cg-RX-API-DMAC7.html) 2022-02-01

Family

ID=65494516

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020541807A Pending JP2021512109A (ja) 2018-01-31 2019-01-31 スピロラクタム系nmda受容体修飾因子およびその使用
JP2023192455A Withdrawn JP2024019396A (ja) 2018-01-31 2023-11-10 スピロラクタム系nmda受容体修飾因子およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023192455A Withdrawn JP2024019396A (ja) 2018-01-31 2023-11-10 スピロラクタム系nmda受容体修飾因子およびその使用

Country Status (15)

Country Link
US (1) US20210047324A1 (cg-RX-API-DMAC7.html)
EP (1) EP3746442A1 (cg-RX-API-DMAC7.html)
JP (2) JP2021512109A (cg-RX-API-DMAC7.html)
KR (1) KR20200115610A (cg-RX-API-DMAC7.html)
CN (1) CN112218866A (cg-RX-API-DMAC7.html)
AU (1) AU2019215049A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020015666A2 (cg-RX-API-DMAC7.html)
CA (1) CA3089559A1 (cg-RX-API-DMAC7.html)
CL (1) CL2020001990A1 (cg-RX-API-DMAC7.html)
IL (1) IL276330A (cg-RX-API-DMAC7.html)
MX (1) MX2020008106A (cg-RX-API-DMAC7.html)
PE (1) PE20211455A1 (cg-RX-API-DMAC7.html)
PH (1) PH12020551140A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202007251XA (cg-RX-API-DMAC7.html)
WO (1) WO2019152678A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2898861C (en) 2013-01-29 2021-07-20 Naurex, Inc. Spiro-lactam nmda receptor modulators and uses thereof
PE20190501A1 (es) 2016-08-01 2019-04-10 Aptinyx Inc Moduladores nmda espiro-lactam y metodos de uso de los mismos
CA3031534C (en) 2016-08-01 2023-10-17 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
EP3490992B1 (en) 2016-08-01 2023-03-22 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
CN109890825B (zh) 2016-08-01 2022-03-11 阿普廷伊克斯股份有限公司 螺-内酰胺nmda受体调节剂及其用途
PE20210455A1 (es) 2018-01-31 2021-03-08 Aptinyx Inc Moduladores del receptor nmda espiro-lactama y usos de los mismos
AU2019227607C1 (en) 2018-02-27 2023-07-20 Incyte Corporation Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
EP3810610A1 (en) 2018-05-18 2021-04-28 Incyte Corporation Fused pyrimidine derivatives as a2a / a2b inhibitors
CN117304191A (zh) 2018-07-05 2023-12-29 因赛特公司 作为a2a/a2b抑制剂的稠合吡嗪衍生物
TWI829857B (zh) 2019-01-29 2024-01-21 美商英塞特公司 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
US12012413B2 (en) 2019-11-11 2024-06-18 Tenacia Biotechnology (Hong Kong) Co., Limited Methods of treating painful diabetic peripheral neuropathy
WO2024054919A1 (en) * 2022-09-08 2024-03-14 Tenacia Biotechnology (Hong Kong) Co., Limited Spiro-lactam nmda receptor modulators and uses thereof
AU2024354932A1 (en) * 2023-10-03 2026-04-09 Revolution Medicines, Inc. Synthesis of ras inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011003015A (es) * 2008-09-18 2011-11-18 Univ Northwestern Moduladores del receptor de n-metil-d-aspartato, y usos de los mismos.
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
SG10201501050RA (en) * 2010-02-11 2015-04-29 Univ Northwestern Secondary Structure Stabilized NMDA Receptor Modulators And Uses Thereof
CN102267995A (zh) * 2010-06-04 2011-12-07 艾琪康医药科技(上海)有限公司 一种制备二氮杂螺环化合物的方法
JP6419087B2 (ja) * 2013-01-29 2018-11-07 アプティニックス インコーポレイテッド スピロラクタム系nmda受容体モジュレーターおよびその使用
SG11201505937SA (en) * 2013-01-29 2015-09-29 Naurex Inc Spiro-lactam nmda receptor modulators and uses thereof
CA2898861C (en) * 2013-01-29 2021-07-20 Naurex, Inc. Spiro-lactam nmda receptor modulators and uses thereof
WO2014120784A1 (en) * 2013-01-29 2014-08-07 Naurex, Inc. Spiro-lactam nmda receptor modulators and uses thereof
CN105308049A (zh) * 2013-01-29 2016-02-03 阿普廷伊克斯股份有限公司 螺-内酰胺nmda受体调节剂及其用途
EP3277690B1 (en) * 2015-04-03 2020-02-26 Recurium IP Holdings, LLC Spirocyclic compounds
PE20190174A1 (es) * 2016-05-19 2019-02-01 Aptinyx Inc Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos
WO2017201285A1 (en) * 2016-05-19 2017-11-23 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
EP3490992B1 (en) * 2016-08-01 2023-03-22 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
AR110988A1 (es) * 2017-02-21 2019-05-22 Sanofi Sa Compuestos de azetidina como moduladores de gpr119 para el tratamiento de la diabetes, la obesidad, la dislipidemia y trastornos relacionados
JP2022092387A (ja) * 2020-12-10 2022-06-22 キヤノン株式会社 画像形成装置

Similar Documents

Publication Publication Date Title
JP2021512098A5 (cg-RX-API-DMAC7.html)
JP2024520481A5 (cg-RX-API-DMAC7.html)
HRP20241540T1 (hr) Pirolotriazinski spojevi koji djeluju kao inhibitor mnk
RU2018104278A (ru) Оксистеролы и способы их применения
JP2021527638A5 (cg-RX-API-DMAC7.html)
HRP20210926T1 (hr) Derivati 1h-indazol-3-karboksamida i povezani spojevi kao inhibitori faktora d za liječenje bolesti karakteriziranih pojačanom djelatnošću sustava komplemenata, kao npr. imunološki poremećaji
HRP20241020T1 (hr) Makrociklički spoj koji služi kao wee1 inhibitor i njegove primjene
AR066904A1 (es) Pirrolopiridinas y pirazolopiridinas sustituidas como moduladores de las quinasas, una composicion farmaceutica que las incluye y su uso en el tratamiento del cancer
ME02875B (me) Inhibitori hcv polimeraze
JP2020504707A5 (cg-RX-API-DMAC7.html)
JP2017531020A5 (cg-RX-API-DMAC7.html)
JP2021524440A5 (cg-RX-API-DMAC7.html)
JP2016503052A5 (cg-RX-API-DMAC7.html)
JP2014051526A5 (cg-RX-API-DMAC7.html)
RU2017136715A (ru) Производное имидазоизоиндола, способ его получения и медицинское применение
JP2021508318A5 (cg-RX-API-DMAC7.html)
JP2010510237A5 (cg-RX-API-DMAC7.html)
AR080878A1 (es) Derivados heterociclicos de ariletinilo, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos en el tratamiento de la esquizofrenia y trastornos cognitivos.
IL276332B1 (en) Spiro-lactam nmda receptor modulators and uses thereof
RU2019116512A (ru) Ингибиторы magl
RU2018145808A (ru) Производное фенилпропанамида, способ его получения и его фармацевтическое применение
JP2023533203A5 (cg-RX-API-DMAC7.html)
RU2020131276A (ru) Терапевтические соединения и композиции
AR105522A1 (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor
RU2008107733A (ru) Ингибиторы gsk-3